Available by prescription only, INCIVEK is used to treat chronic hepatitis C infections. It comes in the form of a tablet and is taken by mouth two times a day for 12 weeks. This medicine works by blocking the action of certain enzymes in the body, which prevents the hepatitis C virus from reproducing. Side effects may include nausea, vomiting, and diarrhea.
What Is INCIVEK?
INCIVEK® (telaprevir) is a prescription medication approved to treat chronic hepatitis C infections. It is always used in combination with two other hepatitis C medications: peginterferon alfa (Pegasys®, PEG-Intron®) and ribavirin (Copegus®, Rebetol®, RibaPak®, Ribasphere®). INCIVEK is only approved for use in people who have stable liver problems and have not been treated before or have failed previous treatment.
INCIVEK is made by Vertex Pharmaceuticals Incorporated.
How Does INCIVEK Work?
INCIVEK belongs to a group of medications called protease inhibitors. It works by inhibiting the activity of enzymes called proteases. Protease enzymes are used by the hepatitis C virus to clip long protein strands into shorter, usable strands. The virus then uses these shorter strands to replicate itself (reproduce). By blocking the protease enzyme, INCIVEK prevents the hepatitis C virus from reproducing.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed February 21, 2012.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2008.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click